Clinical trial ISRCTN14688109
Status: Recruiting (according to the registry)Phase not statedLatest change: Source: ISRCTN (United Kingdom) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in May 7, 2015 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Investigation of the potential beneficial effects of cannabidiol in the treatment of tardive dyskinesia
- Record number
- ISRCTN14688109
- Registry
- ISRCTN (United Kingdom) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase not stated
- Participants
- Target: 60
- Condition (as registered)
- Tardive dyskinesia, Nervous System Diseases, Drug-induced dystonia
- Countries
- Nigeria
- Topic in the guide
- Skin Conditions
Timeline
According to the ISRCTN (United Kingdom) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: May 7, 2015
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Skin Conditions: guide page · Thinking of taking part? Which specialist to see